HopeStage
Back to all studies
RecruitingNCT07398469

Patient-reported postpartum depression symptoms after starting zuranolone

About this titleRead the official source — NCT07398469
Observational studyAges 18+United States
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
CambridgeSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 22, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
300
Sponsor
Biogen
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Medication / drug
Study phase
Not clearly listed
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT07398469
Official title
Show the full official title

A Longitudinal Online Survey of Patient-Reported Changes in Postpartum Depression Symptoms Following Zuranolone Use

Recruitment & locations

Recruiting

Cambridge

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Biogen.

Does this study involve medication?

Yes. The study involves medication, including Zuranolone.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies